Search Results

Urgent action is needed as superbugs threaten to claim 40 million lives by 2050, according to new research. (Wikimedia Commons)
Ankur Deka
2 min read
Lancet study reveals rising threat of antimicrobial resistance and urges immediate action to prevent millions of deaths
It’s ‘lights out’ for antibiotic-resistant superbugs as next-generation light-activated nanotech proves it can eradicate some of the most notorious and potentially deadly bacteria in the world. (WIKIMEDIA COMMONS)
MBT Desk
3 min read
It’s ‘lights out’ for antibiotic-resistant superbugs as next-generation light-activated nanotech proves it can eradicate some of the most notorious and potentially deadly bacteria in the world.
BPaL’s 6-month regimen for drug-resistant TB to be launched nationwide in January after training sessions conclude. (Wikimedia Commons)
Ankur Deka
2 min read
Six-month regimen expected to improve treatment outcomes; training sessions underway for doctors across Indian states
Melanoma with Drug Resistance: Cause Identified. (Pexels)
MBT Desk
2 min read
A new key mechanism has been identified behind the resistance of melanoma to BRAF inhibitors.
India introduced the BPaLM regimen for MDR-TB, which includes Bedaquiline, Pretomanid, Linezolid, and (with or without) Moxifloxacin. It is a newer, shorter regimen, often completed in less than 6 months. ( Representational image : Unsplash )
Yash Kiran Kamble
3 min read
Tuberculosis (TB) remains one of the world's deadliest infectious diseases, particularly in developing regions
New training program aims to equip healthcare workers with skills to manage drug-resistant TB, offering hope through advanced treatment regimens.(Unsplash)
Ankur Deka
3 min read
Nationwide initiative aims to equip healthcare professionals with the skills to administer and manage cutting-edge treatment for multi-drug-resistant tuberculosis
Read More
logo
Medbound
www.medboundtimes.com